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Abstract
Multiple sclerosis (MS) is a demyelinating disorder of
the central nervous system, characterized by immunemediated destruction of myelinated axons, which leads
to notable physical disability. Although presence among
active athletes is extremely low, it can cause considerable
lifestyle changes for those athletes affected as they
transition into life after competitive athletics. We describe
a 29-year-old former collegiate women’s basketball player
in whom MS was diagnosed during a visit for recurrent
evaluation of Bell palsy. Subsequent neurology consult and
magnetic resonance imaging led to the confirmation of
the diagnosis of MS, and the patient began treatment for
relapsing-remitting MS. During visits of what appear to be
straightforward neurological symptoms, it is imperative
to collect a full neurologic history and perform a detailed
physical examination to determine whether a more
systemic disease process could be at fault, which may
subsequently lead to earlier detection and treatment of MS.

Introduction
Multiple sclerosis (MS) is an immune-mediated,
demyelinating disease that affects the central nervous
system—leading to considerable physical disability.1 MS
currently affects more than two million people worldwide
according to the National Multiple Sclerosis Society, and
current estimates state that more than 400,000 individuals
are affected in the United States.1 Recent data show that
MS affects more women than men by a two-to-one ratio.2
Patient age at diagnosis is traditionally between 20 to 50
years.1
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Numerous hypotheses exist as to which individuals
get MS, but most experts agree that it is a combination
of genetic and environmental factors. Genetic factors
comprise mainly ethnicity and sex, with current research
directed toward specific single-nucleotide polymorphisms
and histocompatibility complexes.3,4 Environmental factors
include geography and vitamin-D factors (eg, the closer
that patients live to the equator, the less likely they are
to get MS); additionally, higher levels of vitamin D are
thought to be protective against MS.5-7
The diagnostic criteria for MS have gradually changed.
For the 2010 revision to the McDonald criteria, the goal
was to simplify the ability to show lesions in space and
time with the help of magnetic resonance imaging (MRI)
(Figure 1). MS is typically divided into four categories:
relapsing-remitting, secondary progressive, primary
progressive, and progressive-relapsing, with relapsingremitting being the most common criterion.8
Treatment of MS is typically divided into acute attacks
and disease-modifying agents. Acute attacks are treated
with a burst of corticosteroids, whereas disease-modifying
agents (including glatiramer acetate, interferon, and
natalizumab) are used in attempt to reduce frequency of
relapse.9 We describe diagnosis of MS in a former collegiate
athlete who initially had presented with symptoms of Bell’s
palsy. The patient was informed that the data concerning
her case would be submitted for publication, and she
provided verbal consent.
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Figure 1. The revised diagnostic criteria in 2010 for multiple sclerosis, used by the National Multiple Sclerosis Society. (Diagnostic
criteria. National Multiple Sclerosis Society website. http://www.nationalmssociety.org/For-Professionals/Clinical-Care/DiagnosingMS/Diagnosing-Criteria. Accessed February 4, 2017).

Case Report
A 29-year-old former collegiate basketball player presented
to our sports-medicine clinic with concern for Bell’s palsy.
She had reported that this was the second occurrence of
Bell’s palsy; she had experienced a similar episode about
a year earlier, which resolved after a 5-day treatment of
oral corticosteroid. She reported the inability to fully close
her left eye since the onset of symptoms, about 7 to 10
days before presentation to our clinic. She also reported
some fullness in her right ear. She did not mention any
hyperacusis, loss of taste, numbness, tingling of her
extremities, or diffuse weakness. She did report some mild
blurry vision in her left eye along with some lateral gaze
disturbance, but she attributed this to her inability to close
the eye fully and said that this was similar to her last bout
of Bell’s palsy 1 year earlier. Additionally, the patient did
not have any recent viral infection of the upper respiratory
system or other viral prodrome.
On physical examination, results of the Head, Eye, Ear,
Nose and Throat test and neurological examination were
remarkable for inability to raise the left eyebrow. Her left
eye could only be covered with full, maximal effort. Upon
smiling, the left side of her mouth was noted to not raise
as much as the right side to produce an asymmetrical
smile. Additionally, the patient was noted to have end-gaze
nystagmus on both eyes.

The patient was discharged from the clinic with a
5-day, 60-mg prednisone burst for Bell’s palsy treatment;
however, owing to presence of nystagmus, we consulted our
colleagues in neurology for additional recommendations.
Neurologists agreed with the current treatment plan and
diagnosis because of the lack of other systemic symptoms,
but they advised to have a low threshold to get an MRI
owing to concern for mass, a tumor of the central nervous
system, cavernous sinus aneurysm, or MS.
At 1 week after the initial visit to our clinic, the patient
returned for scheduled follow-up. Her facial palsy
was improved, but she continued to report lateral gaze
disturbance and occasional diplopia, which worsened
during lateral gaze. She noted these symptoms the most
while playing pick-up basketball and during kickboxing
class. While playing basketball, she also suffered from an
unusual sluggishness and “couldn’t move normally.” She
did not report any history of diplopia or blurry vision
during periods of raised internal temperature. We again
discussed the case with neurologists, who recommended
to further assess the patient’s symptoms with an MRI,
magnetic resonance angiography, and additional blood
examinations (ie, tests for complete blood count;
C-reactive protein levels; erythrocyte sedimentation
rate; chemical substance levels; liver function; human
immunodeficiency virus; treponema; and antinuclear
antibody count). Because of concern for cavernous sinus
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aneurysm, the patient was instructed to not work out or
do any activities that would raise her blood pressure in the
interim.
Results of laboratory studies were remarkable for a
mildly elevated creatinine count to 1.16; total bilirubin
count of 1.3 (direct, 0.3); and positive antinuclear antibody
count, with a titer of less than 1:40. An MRI was obtained
on the night of her second clinic visit
(Figures 2A and 2B). The image revealed an abnormal
moderate amount of scattered areas of cerebral and
brainstem T2 prolongation, with distribution and
formation suggestive of demyelinating plaques of MS.
Multiple areas of T2 prolongation showed postcontrast
enhancement. Differential consideration included collagen
vascular disease and vasculitis, although this was thought
less likely.

A

B

Figure 2. T2-weighted magnetic resonance imaging at 1 week
after initial presentation. A) Abnormal moderate amount of
scattered areas of cerebral T2 prolongation, with distribution
and morphological features (arrows) suggestive of demyelinating
plaques of multiple sclerosis. B) Specific lesion (arrow) of T2
prolongation in the pons, which may explain the patient’s
symptoms of palsy during lateral gaze.

The patient was referred to a neurology clinic for
management of suspected MS. At that visit, the patient
reported intermittent numbness of her left calf and left
side of her trunk for the past 5 months, which were not
reported during her initial visit for Bell’s palsy. Her scan
was reviewed in detail by the neurologist, who noted that
the patient had a lesion on the left side of her pons, near
the origin of her sixth and seventh cranial nerves. The
presence of the lesion was consistent with the noted lateral
gaze palsy, associated diplopia on lateral gaze, and facial
nerve paresis. Diagnostic criteria was noted to have been
met for MS on the basis of the “MRI, age, response to
steroids, and duration of symptoms.”
The patient recently underwent treatment with use of
Rebif (interferon beta-1a) and vitamin D. At her most
recent follow-up, she reported an increase in baseline
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left-lower extremity pain and “hotness” during her exercise
class. The neurologist recommended that she have an icecold beverage with her to prevent a rise in her core body
temperature which is known to exacerbate symptoms of
MS.

Discussion
Because MS affects the central nervous system, the disorder
can result in severe limitations to physical activity.1
Although studies have shown benefits from exercise in
regards to a patient’s “overall functional capacity and
psychological well-being” in the presence of MS, the
type of exercise should be discussed and exposure to heat
should be limited.10
The current case fits a typical description of a patient
with MS. Our patient was a woman aged 29 years, with
an initial attack responding to a burst of steroids and
a relapse about 1 year after. Perhaps a more thorough
evaluation at her initial clinic visit could have elicited the
report of left lower extremity numbness as indicated when
she saw the neurologist. However, the sports-medicine
physicians correctly suspected a more systemic process;
thus, neurologists were consulted immediately. Although
recurrent Bell’s palsy may occur, it is very rare. In one of
the largest studies involving Bell’s palsy, it was determined
that only 7% of patients had a recurrence, and mean time
to recurrence was 10 years.11
As such, the findings of this case can serve as a reminder
that patients who present with symptoms of Bell’s
palsy, especially a recurrent symptom, should get a full
neurological examination, with specific focus on the timing
of symptoms in relation to activity; and an increase in core
body temperature.
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